Change in the total number of shares and votes in Recipharm AB (publ)

In June 2015, the number of shares in Recipharm AB (publ) (“Recipharm”) has
increased by 45 838 shares of series B, corresponding to 45 838 votes. The
increase in the number of shares and votes results from the issue in kind in
connection with the acquisition of OT Chemistry AB, which was finalised 15 June
2015.

As of 30 June 2015, the total number of shares in Recipharm amounts to
45 765 256, divided into 12,685,716 shares of series A and 33 079 540 shares of
series B. The total number of votes in Recipharm as of 30 June 2015 amounts to
159 936 700.

For further information please visit www.recipharm.com or contact:

Thomas Eldered, CEO, thomas.eldered@recipharm.com, telephone: +46 8 602 52 10

Björn Westberg, CFO, bjorn.westberg@recipharm.com, telephone: +46 8 602 46 20

This information is published in accordance with Chapter 4, Section 9 of the
Swedish Financial Instruments Trading Act (SFS 1991:980).This information was
submitted for publication on 30 June 2015, at 08:00 am CET.
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52
00, Fax 46 8 81 87 03
www.recipharm.com